BIND Therapeutics Initiates Voluntary Chapter 11 Bankruptcy Protection Proceeding
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St to open higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Stifel Downgrades BIND Therapeutics (BIND) to Hold Following Chapter 11
May 2, 2016 1:12 PM EDTStifel downgraded BIND Therapeutics (NASDAQ: BIND) from Buy to Hold following Chapter 11 filing.
For an analyst ratings summary and ratings history on BIND Therapeutics click here. For more ratings news on BIND Therapeutics click here.
Shares of BIND Therapeutics closed at $1.45 yesterday.
... MoreBIND Therapeutics (BIND) Announces Receipt of Notice of Default
May 2, 2016 6:28 AM EDTBIND Therapeutics (NASDAQ: BIND) disclosed the following on Monday:
Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
On April 26, 2016, the Company received a notice (the Notice) from Hercules Technology III, L.P. (Hercules) asserting that an event of default had occurred under the Companys amended and restated credit facility (as amended, the Credit Facility) with Hercules as lender. Pursuant to the Credit Facility, Hercules extended the... More
